nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—Lethargy—Floxuridine—stomach cancer	0.0327	0.035	CcSEcCtD
Bretylium—Angina pectoris—Floxuridine—stomach cancer	0.027	0.0289	CcSEcCtD
Bretylium—Rash macular—Capecitabine—stomach cancer	0.0246	0.0263	CcSEcCtD
Bretylium—Tenderness—Fluorouracil—stomach cancer	0.0165	0.0177	CcSEcCtD
Bretylium—Confusional state—Floxuridine—stomach cancer	0.0159	0.017	CcSEcCtD
Bretylium—Hiccups—Irinotecan—stomach cancer	0.0151	0.0161	CcSEcCtD
Bretylium—Syncope—Mitomycin—stomach cancer	0.0136	0.0145	CcSEcCtD
Bretylium—Loss of consciousness—Mitomycin—stomach cancer	0.0133	0.0143	CcSEcCtD
Bretylium—Hypertension—Mitomycin—stomach cancer	0.0131	0.014	CcSEcCtD
Bretylium—Feeling abnormal—Floxuridine—stomach cancer	0.013	0.0139	CcSEcCtD
Bretylium—Gastrointestinal pain—Floxuridine—stomach cancer	0.0129	0.0138	CcSEcCtD
Bretylium—Confusional state—Mitomycin—stomach cancer	0.0125	0.0133	CcSEcCtD
Bretylium—Abdominal pain—Floxuridine—stomach cancer	0.0125	0.0133	CcSEcCtD
Bretylium—Body temperature increased—Floxuridine—stomach cancer	0.0125	0.0133	CcSEcCtD
Bretylium—Shock—Mitomycin—stomach cancer	0.0122	0.013	CcSEcCtD
Bretylium—ATP1A1—gall bladder—stomach cancer	0.0118	0.181	CbGeAlD
Bretylium—Ventricular extrasystoles—Capecitabine—stomach cancer	0.0112	0.0119	CcSEcCtD
Bretylium—Dyspnoea—Mitomycin—stomach cancer	0.011	0.0118	CcSEcCtD
Bretylium—Diarrhoea—Floxuridine—stomach cancer	0.0108	0.0115	CcSEcCtD
Bretylium—Lethargy—Fluorouracil—stomach cancer	0.0107	0.0114	CcSEcCtD
Bretylium—Feeling abnormal—Mitomycin—stomach cancer	0.0102	0.0109	CcSEcCtD
Bretylium—Hiccups—Capecitabine—stomach cancer	0.0101	0.0108	CcSEcCtD
Bretylium—Vomiting—Floxuridine—stomach cancer	0.01	0.0107	CcSEcCtD
Bretylium—Orthostatic hypotension—Irinotecan—stomach cancer	0.00998	0.0107	CcSEcCtD
Bretylium—Body temperature increased—Mitomycin—stomach cancer	0.00978	0.0105	CcSEcCtD
Bretylium—Nausea—Floxuridine—stomach cancer	0.00937	0.01	CcSEcCtD
Bretylium—Lightheadedness—Docetaxel—stomach cancer	0.00931	0.00996	CcSEcCtD
Bretylium—Sweating increased—Irinotecan—stomach cancer	0.0092	0.00984	CcSEcCtD
Bretylium—Angina pectoris—Irinotecan—stomach cancer	0.0092	0.00984	CcSEcCtD
Bretylium—Angina pectoris—Fluorouracil—stomach cancer	0.00882	0.00943	CcSEcCtD
Bretylium—Diarrhoea—Mitomycin—stomach cancer	0.00847	0.00905	CcSEcCtD
Bretylium—Dizziness—Mitomycin—stomach cancer	0.00818	0.00875	CcSEcCtD
Bretylium—Vomiting—Mitomycin—stomach cancer	0.00787	0.00841	CcSEcCtD
Bretylium—Conjunctivitis—Fluorouracil—stomach cancer	0.00784	0.00839	CcSEcCtD
Bretylium—Ventricular extrasystoles—Epirubicin—stomach cancer	0.00777	0.00832	CcSEcCtD
Bretylium—Lethargy—Docetaxel—stomach cancer	0.00771	0.00825	CcSEcCtD
Bretylium—Bradycardia—Irinotecan—stomach cancer	0.0077	0.00824	CcSEcCtD
Bretylium—Lethargy—Capecitabine—stomach cancer	0.00747	0.00799	CcSEcCtD
Bretylium—Nausea—Mitomycin—stomach cancer	0.00735	0.00786	CcSEcCtD
Bretylium—Ventricular extrasystoles—Doxorubicin—stomach cancer	0.00719	0.00769	CcSEcCtD
Bretylium—Hiccups—Epirubicin—stomach cancer	0.00702	0.00751	CcSEcCtD
Bretylium—Flushing—Irinotecan—stomach cancer	0.00702	0.00751	CcSEcCtD
Bretylium—Mood swings—Capecitabine—stomach cancer	0.00693	0.00741	CcSEcCtD
Bretylium—Orthostatic hypotension—Docetaxel—stomach cancer	0.0069	0.00738	CcSEcCtD
Bretylium—Orthostatic hypotension—Capecitabine—stomach cancer	0.00668	0.00715	CcSEcCtD
Bretylium—ATP1A1—hematopoietic system—stomach cancer	0.00666	0.102	CbGeAlD
Bretylium—Hiccups—Doxorubicin—stomach cancer	0.0065	0.00695	CcSEcCtD
Bretylium—Angina pectoris—Docetaxel—stomach cancer	0.00636	0.00681	CcSEcCtD
Bretylium—Angina pectoris—Capecitabine—stomach cancer	0.00616	0.00659	CcSEcCtD
Bretylium—Sweating increased—Capecitabine—stomach cancer	0.00616	0.00659	CcSEcCtD
Bretylium—ATP1A1—epithelium—stomach cancer	0.00609	0.0936	CbGeAlD
Bretylium—Vertigo—Irinotecan—stomach cancer	0.00592	0.00633	CcSEcCtD
Bretylium—Syncope—Irinotecan—stomach cancer	0.0059	0.00632	CcSEcCtD
Bretylium—ATP1A1—smooth muscle tissue—stomach cancer	0.00587	0.0902	CbGeAlD
Bretylium—Loss of consciousness—Irinotecan—stomach cancer	0.00579	0.00619	CcSEcCtD
Bretylium—Hypertension—Irinotecan—stomach cancer	0.00568	0.00608	CcSEcCtD
Bretylium—Conjunctivitis—Docetaxel—stomach cancer	0.00566	0.00605	CcSEcCtD
Bretylium—Lethargy—Methotrexate—stomach cancer	0.00556	0.00595	CcSEcCtD
Bretylium—Conjunctivitis—Capecitabine—stomach cancer	0.00548	0.00586	CcSEcCtD
Bretylium—ATP1A1—pancreas—stomach cancer	0.00542	0.0834	CbGeAlD
Bretylium—Confusional state—Irinotecan—stomach cancer	0.00542	0.00579	CcSEcCtD
Bretylium—Shock—Irinotecan—stomach cancer	0.00529	0.00565	CcSEcCtD
Bretylium—Lethargy—Epirubicin—stomach cancer	0.0052	0.00556	CcSEcCtD
Bretylium—Hyperhidrosis—Irinotecan—stomach cancer	0.00519	0.00556	CcSEcCtD
Bretylium—Confusional state—Fluorouracil—stomach cancer	0.00519	0.00555	CcSEcCtD
Bretylium—Mood swings—Methotrexate—stomach cancer	0.00516	0.00552	CcSEcCtD
Bretylium—Bradycardia—Capecitabine—stomach cancer	0.00515	0.00551	CcSEcCtD
Bretylium—Affect lability—Epirubicin—stomach cancer	0.00502	0.00537	CcSEcCtD
Bretylium—Flushing—Docetaxel—stomach cancer	0.00485	0.00519	CcSEcCtD
Bretylium—Mood swings—Epirubicin—stomach cancer	0.00483	0.00516	CcSEcCtD
Bretylium—Lethargy—Doxorubicin—stomach cancer	0.00481	0.00515	CcSEcCtD
Bretylium—Dyspnoea—Irinotecan—stomach cancer	0.00479	0.00512	CcSEcCtD
Bretylium—Flushing—Capecitabine—stomach cancer	0.0047	0.00502	CcSEcCtD
Bretylium—ATP1A1—lymphoid tissue—stomach cancer	0.00469	0.0721	CbGeAlD
Bretylium—Orthostatic hypotension—Epirubicin—stomach cancer	0.00466	0.00498	CcSEcCtD
Bretylium—Affect lability—Doxorubicin—stomach cancer	0.00464	0.00497	CcSEcCtD
Bretylium—ATP1A1—digestive system—stomach cancer	0.00463	0.0712	CbGeAlD
Bretylium—Dyspnoea—Fluorouracil—stomach cancer	0.00459	0.00491	CcSEcCtD
Bretylium—Mood swings—Doxorubicin—stomach cancer	0.00447	0.00478	CcSEcCtD
Bretylium—Feeling abnormal—Irinotecan—stomach cancer	0.00443	0.00474	CcSEcCtD
Bretylium—Gastrointestinal pain—Irinotecan—stomach cancer	0.00439	0.0047	CcSEcCtD
Bretylium—Orthostatic hypotension—Doxorubicin—stomach cancer	0.00431	0.00461	CcSEcCtD
Bretylium—Angina pectoris—Epirubicin—stomach cancer	0.00429	0.00459	CcSEcCtD
Bretylium—ATP1A1—bone marrow—stomach cancer	0.00427	0.0656	CbGeAlD
Bretylium—Body temperature increased—Irinotecan—stomach cancer	0.00425	0.00454	CcSEcCtD
Bretylium—Abdominal pain—Irinotecan—stomach cancer	0.00425	0.00454	CcSEcCtD
Bretylium—Feeling abnormal—Fluorouracil—stomach cancer	0.00424	0.00454	CcSEcCtD
Bretylium—Syncope—Docetaxel—stomach cancer	0.00408	0.00437	CcSEcCtD
Bretylium—Conjunctivitis—Methotrexate—stomach cancer	0.00408	0.00436	CcSEcCtD
Bretylium—Body temperature increased—Fluorouracil—stomach cancer	0.00407	0.00435	CcSEcCtD
Bretylium—Loss of consciousness—Docetaxel—stomach cancer	0.004	0.00428	CcSEcCtD
Bretylium—Angina pectoris—Doxorubicin—stomach cancer	0.00397	0.00425	CcSEcCtD
Bretylium—Vertigo—Capecitabine—stomach cancer	0.00396	0.00423	CcSEcCtD
Bretylium—Syncope—Capecitabine—stomach cancer	0.00395	0.00423	CcSEcCtD
Bretylium—Hypertension—Docetaxel—stomach cancer	0.00393	0.0042	CcSEcCtD
Bretylium—Loss of consciousness—Capecitabine—stomach cancer	0.00387	0.00414	CcSEcCtD
Bretylium—ATP1A1—endocrine gland—stomach cancer	0.00383	0.0588	CbGeAlD
Bretylium—Conjunctivitis—Epirubicin—stomach cancer	0.00382	0.00408	CcSEcCtD
Bretylium—Hypertension—Capecitabine—stomach cancer	0.0038	0.00407	CcSEcCtD
Bretylium—Confusional state—Docetaxel—stomach cancer	0.00375	0.00401	CcSEcCtD
Bretylium—Anxiety—Capecitabine—stomach cancer	0.00374	0.004	CcSEcCtD
Bretylium—Diarrhoea—Irinotecan—stomach cancer	0.00368	0.00393	CcSEcCtD
Bretylium—Shock—Docetaxel—stomach cancer	0.00365	0.00391	CcSEcCtD
Bretylium—Confusional state—Capecitabine—stomach cancer	0.00363	0.00388	CcSEcCtD
Bretylium—Bradycardia—Epirubicin—stomach cancer	0.00359	0.00384	CcSEcCtD
Bretylium—Dizziness—Irinotecan—stomach cancer	0.00355	0.0038	CcSEcCtD
Bretylium—Shock—Capecitabine—stomach cancer	0.00354	0.00378	CcSEcCtD
Bretylium—Conjunctivitis—Doxorubicin—stomach cancer	0.00353	0.00378	CcSEcCtD
Bretylium—Diarrhoea—Fluorouracil—stomach cancer	0.00352	0.00377	CcSEcCtD
Bretylium—Hyperhidrosis—Capecitabine—stomach cancer	0.00348	0.00372	CcSEcCtD
Bretylium—ATP1A1—liver—stomach cancer	0.00345	0.053	CbGeAlD
Bretylium—Vomiting—Irinotecan—stomach cancer	0.00342	0.00365	CcSEcCtD
Bretylium—Dizziness—Fluorouracil—stomach cancer	0.0034	0.00364	CcSEcCtD
Bretylium—SLC6A2—endocrine gland—stomach cancer	0.0034	0.0523	CbGeAlD
Bretylium—Bradycardia—Doxorubicin—stomach cancer	0.00332	0.00355	CcSEcCtD
Bretylium—Dyspnoea—Docetaxel—stomach cancer	0.00331	0.00354	CcSEcCtD
Bretylium—Flushing—Epirubicin—stomach cancer	0.00327	0.0035	CcSEcCtD
Bretylium—Vomiting—Fluorouracil—stomach cancer	0.00327	0.0035	CcSEcCtD
Bretylium—Dyspnoea—Capecitabine—stomach cancer	0.00321	0.00343	CcSEcCtD
Bretylium—Nausea—Irinotecan—stomach cancer	0.00319	0.00341	CcSEcCtD
Bretylium—Feeling abnormal—Docetaxel—stomach cancer	0.00306	0.00327	CcSEcCtD
Bretylium—Nausea—Fluorouracil—stomach cancer	0.00306	0.00327	CcSEcCtD
Bretylium—Gastrointestinal pain—Docetaxel—stomach cancer	0.00304	0.00325	CcSEcCtD
Bretylium—Flushing—Doxorubicin—stomach cancer	0.00303	0.00324	CcSEcCtD
Bretylium—Feeling abnormal—Capecitabine—stomach cancer	0.00296	0.00317	CcSEcCtD
Bretylium—Vertigo—Methotrexate—stomach cancer	0.00295	0.00315	CcSEcCtD
Bretylium—Gastrointestinal pain—Capecitabine—stomach cancer	0.00294	0.00315	CcSEcCtD
Bretylium—Abdominal pain—Docetaxel—stomach cancer	0.00294	0.00314	CcSEcCtD
Bretylium—Body temperature increased—Docetaxel—stomach cancer	0.00294	0.00314	CcSEcCtD
Bretylium—Abdominal pain—Capecitabine—stomach cancer	0.00284	0.00304	CcSEcCtD
Bretylium—Body temperature increased—Capecitabine—stomach cancer	0.00284	0.00304	CcSEcCtD
Bretylium—Vertigo—Epirubicin—stomach cancer	0.00276	0.00295	CcSEcCtD
Bretylium—Syncope—Epirubicin—stomach cancer	0.00275	0.00294	CcSEcCtD
Bretylium—Confusional state—Methotrexate—stomach cancer	0.0027	0.00289	CcSEcCtD
Bretylium—Loss of consciousness—Epirubicin—stomach cancer	0.0027	0.00289	CcSEcCtD
Bretylium—Hypertension—Epirubicin—stomach cancer	0.00265	0.00283	CcSEcCtD
Bretylium—ATP1A1—lymph node—stomach cancer	0.00265	0.0407	CbGeAlD
Bretylium—Anxiety—Epirubicin—stomach cancer	0.0026	0.00279	CcSEcCtD
Bretylium—Hyperhidrosis—Methotrexate—stomach cancer	0.00259	0.00277	CcSEcCtD
Bretylium—Vertigo—Doxorubicin—stomach cancer	0.00255	0.00273	CcSEcCtD
Bretylium—Syncope—Doxorubicin—stomach cancer	0.00255	0.00272	CcSEcCtD
Bretylium—Diarrhoea—Docetaxel—stomach cancer	0.00254	0.00272	CcSEcCtD
Bretylium—Confusional state—Epirubicin—stomach cancer	0.00253	0.0027	CcSEcCtD
Bretylium—Loss of consciousness—Doxorubicin—stomach cancer	0.0025	0.00267	CcSEcCtD
Bretylium—Shock—Epirubicin—stomach cancer	0.00246	0.00264	CcSEcCtD
Bretylium—Diarrhoea—Capecitabine—stomach cancer	0.00246	0.00263	CcSEcCtD
Bretylium—Dizziness—Docetaxel—stomach cancer	0.00246	0.00263	CcSEcCtD
Bretylium—Hypertension—Doxorubicin—stomach cancer	0.00245	0.00262	CcSEcCtD
Bretylium—Hyperhidrosis—Epirubicin—stomach cancer	0.00242	0.00259	CcSEcCtD
Bretylium—Anxiety—Doxorubicin—stomach cancer	0.00241	0.00258	CcSEcCtD
Bretylium—Dyspnoea—Methotrexate—stomach cancer	0.00239	0.00255	CcSEcCtD
Bretylium—Dizziness—Capecitabine—stomach cancer	0.00238	0.00254	CcSEcCtD
Bretylium—Vomiting—Docetaxel—stomach cancer	0.00236	0.00253	CcSEcCtD
Bretylium—SLC6A2—lymph node—stomach cancer	0.00235	0.0361	CbGeAlD
Bretylium—Confusional state—Doxorubicin—stomach cancer	0.00234	0.0025	CcSEcCtD
Bretylium—Vomiting—Capecitabine—stomach cancer	0.00229	0.00245	CcSEcCtD
Bretylium—Shock—Doxorubicin—stomach cancer	0.00228	0.00244	CcSEcCtD
Bretylium—Hyperhidrosis—Doxorubicin—stomach cancer	0.00224	0.0024	CcSEcCtD
Bretylium—Dyspnoea—Epirubicin—stomach cancer	0.00223	0.00239	CcSEcCtD
Bretylium—Nausea—Docetaxel—stomach cancer	0.00221	0.00236	CcSEcCtD
Bretylium—Feeling abnormal—Methotrexate—stomach cancer	0.00221	0.00236	CcSEcCtD
Bretylium—Gastrointestinal pain—Methotrexate—stomach cancer	0.00219	0.00234	CcSEcCtD
Bretylium—Nausea—Capecitabine—stomach cancer	0.00214	0.00228	CcSEcCtD
Bretylium—Abdominal pain—Methotrexate—stomach cancer	0.00212	0.00226	CcSEcCtD
Bretylium—Body temperature increased—Methotrexate—stomach cancer	0.00212	0.00226	CcSEcCtD
Bretylium—Dyspnoea—Doxorubicin—stomach cancer	0.00207	0.00221	CcSEcCtD
Bretylium—Feeling abnormal—Epirubicin—stomach cancer	0.00206	0.00221	CcSEcCtD
Bretylium—Gastrointestinal pain—Epirubicin—stomach cancer	0.00205	0.00219	CcSEcCtD
Bretylium—Body temperature increased—Epirubicin—stomach cancer	0.00198	0.00212	CcSEcCtD
Bretylium—Abdominal pain—Epirubicin—stomach cancer	0.00198	0.00212	CcSEcCtD
Bretylium—Feeling abnormal—Doxorubicin—stomach cancer	0.00191	0.00204	CcSEcCtD
Bretylium—Gastrointestinal pain—Doxorubicin—stomach cancer	0.0019	0.00203	CcSEcCtD
Bretylium—Abdominal pain—Doxorubicin—stomach cancer	0.00183	0.00196	CcSEcCtD
Bretylium—Body temperature increased—Doxorubicin—stomach cancer	0.00183	0.00196	CcSEcCtD
Bretylium—Diarrhoea—Methotrexate—stomach cancer	0.00183	0.00196	CcSEcCtD
Bretylium—Dizziness—Methotrexate—stomach cancer	0.00177	0.00189	CcSEcCtD
Bretylium—Diarrhoea—Epirubicin—stomach cancer	0.00171	0.00183	CcSEcCtD
Bretylium—Vomiting—Methotrexate—stomach cancer	0.0017	0.00182	CcSEcCtD
Bretylium—Dizziness—Epirubicin—stomach cancer	0.00166	0.00177	CcSEcCtD
Bretylium—Vomiting—Epirubicin—stomach cancer	0.00159	0.0017	CcSEcCtD
Bretylium—Nausea—Methotrexate—stomach cancer	0.00159	0.0017	CcSEcCtD
Bretylium—Diarrhoea—Doxorubicin—stomach cancer	0.00159	0.0017	CcSEcCtD
Bretylium—Dizziness—Doxorubicin—stomach cancer	0.00153	0.00164	CcSEcCtD
Bretylium—Nausea—Epirubicin—stomach cancer	0.00149	0.00159	CcSEcCtD
Bretylium—Vomiting—Doxorubicin—stomach cancer	0.00147	0.00158	CcSEcCtD
Bretylium—Nausea—Doxorubicin—stomach cancer	0.00138	0.00147	CcSEcCtD
